13F
中

FBIO FORTRESS BIOTECH INC

2026Q1 · CUSIP 34960Q307 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
50
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
26
Δ whales
+2
Inst. holding value
$15M
New positions
13
Closed positions
14
Price momentum (1Q)
—
Put / Call
3/2

Breadth history (34 quarters)

2023Q4: Δ+41 · h=43 2024Q1: Δ-3 · h=40 2024Q2: Δ+11 · h=51 2024Q3: Δ+0 · h=51 2024Q4: Δ+3 · h=54 2025Q1: Δ-7 · h=47 2025Q2: Δ+3 · h=50 2025Q3: Δ+6 · h=56 2025Q4: Δ-5 · h=51 2026Q1: Δ-1 · h=50 2023Q4: holders=43 2024Q1: holders=40 2024Q2: holders=51 2024Q3: holders=51 2024Q4: holders=54 2025Q1: holders=47 2025Q2: holders=50 2025Q3: holders=56 2025Q4: holders=51 2026Q1: holders=50 -41 -20.5 +0 +20.5 +41 364859 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q4 Top 13% +3.8% +4.3%

Options Sentiment

Put holders
3
QoQ: -1
Call holders
2
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
1.1
EPS (TTM)
$3.23
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+14.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $19M 2022-09-30: $17M 2022-12-31: $16M 2023-03-31: $12M 2023-06-30: $17M 2023-09-30: $35M 2023-12-31: $20M 2024-03-31: $13M 2024-06-30: $15M 2024-09-30: $15M 2024-12-31: $15M 2025-03-31: $13M 2025-06-30: $16M 2025-09-30: $18M 2025-12-31: $16M 2026-03-31: $16M 2024-03-31: EPS -1.04 2024-06-30: EPS -0.73 2024-09-30: EPS -0.76 2024-12-31: EPS -0.16 2025-03-31: EPS -0.48 2025-06-30: EPS 0.45 2025-09-30: EPS 0.11 2025-12-31: EPS -0.15 2026-03-31: EPS 2.82 0M 17M 35M $M -1.14 0.98 3.10 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 1 2026-03-31: PE 0.7 1 1 1 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)